Status:
COMPLETED
Evaluation of Potential Off-label Use of Dabigatran Etexilate in Europe
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Brief Summary
This is a descriptive, observational, multi-country European cross-sectional study of new users of dabigatran etexilate that aims to characterise on- and off-label status and other medical characteris...
Detailed Description
Study Design:
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Have at least 1 year of enrolment in the electronic database.
- Have not been prescribed dabigatran etexilate during the 1-year period prior to the index date.
Exclusion
Key Trial Info
Start Date :
November 28 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2016
Estimated Enrollment :
36573 Patients enrolled
Trial Details
Trial ID
NCT02240654
Start Date
November 28 2014
End Date
May 20 2016
Last Update
December 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1160.144.1 Boehringer Ingelheim Investigational Site
Barcelona, Spain